Literature DB >> 15494423

Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK.

Yun Dai1, Mohamed Rahmani, Xin-Yan Pei, Payal Khanna, Song Iy Han, Clint Mitchell, Paul Dent, Steven Grant.   

Abstract

Interactions between the Chk1 inhibitor UCN-01 and the farnesyltransferase inhibitor L744832 were examined in human leukemia cells. Combined exposure of U937 cells to subtoxic concentrations of UCN-01 and L744832 resulted in a dramatic increase in mitochondrial dysfunction, apoptosis, and loss of clonogenicity. Similar interactions were noted in other leukemia cells (HL-60, Raji, Jurkat) and primary acute myeloid leukemia (AML) blasts. Coadministration of L744832 blocked UCN-01-mediated phosphorylation of mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK/ERK), leading to down-regulation of phospho-cyclic adenosine monophosphate responsive element-binding protein (phospho-CREB) and -p90(RSK) and activation of p34(cdc2) and stress-activated protein kinase/ERK kinase/c-Jun N-terminal kinase (SEK/JNK). Combined treatment also resulted in pronounced reductions in levels of phospho-Akt, -glycogen synthase kinase-3 (-GSK-3), -p70(S6K), -mammalian target of rapamycin (-mTOR), -forkhead transcription factor (-FKHR), -caspase-9, and -Bad. Ectopic expression of Bcl-2 or Bcl-xL but not dominant-negative caspase-8 blocked UCN-01/L744832-mediated mitochondrial dysfunction and apoptosis but did not prevent activation of p34(cdc2) and JNK or inactivation of MEK/ERK and Akt. Enforced expression of myristoylated Akt but not constitutively active MEK significantly attenuated UCN-01/L744832-induced apoptosis. However, dual transfection with Akt and MEK resulted in further protection from UCN-01/L744832-mediated lethality. Finally, down-regulation of JNK1 by siRNA significantly reduced the lethality of the UCN-01/L744832 regimen. Together, these findings suggest that farnesyltransferase inhibitors interrupt the cytoprotective Akt and MAPK pathways while reciprocally activating SAPK/JNK in leukemia cells exposed to UCN-01 and, in so doing, dramatically increase mitochondria-dependent apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15494423     DOI: 10.1182/blood-2004-07-2767

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.

Authors:  Andrew J Massey; Peter Stephens; Rebecca Rawlinson; Lauren McGurk; Ruth Plummer; Nicola J Curtin
Journal:  Mol Oncol       Date:  2015-08-25       Impact factor: 6.603

2.  Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.

Authors:  Clint Mitchell; Hossein A Hamed; Nichola Cruickshanks; Yong Tang; M Danielle Bareford; Nissan Hubbard; Gary Tye; Adly Yacoub; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

3.  CHK1 overexpression in T-cell acute lymphoblastic leukemia is essential for proliferation and survival by preventing excessive replication stress.

Authors:  L M Sarmento; V Póvoa; R Nascimento; G Real; I Antunes; L R Martins; C Moita; P M Alves; M Abecasis; L F Moita; R M E Parkhouse; J P P Meijerink; J T Barata
Journal:  Oncogene       Date:  2014-08-18       Impact factor: 9.867

4.  The NF (Nuclear factor)-κB inhibitor parthenolide interacts with histone deacetylase inhibitors to induce MKK7/JNK1-dependent apoptosis in human acute myeloid leukaemia cells.

Authors:  Yun Dai; Monica L Guzman; Shuang Chen; Li Wang; Sin-Kei Yeung; Xin-Yan Pei; Paul Dent; Craig T Jordan; Steven Grant
Journal:  Br J Haematol       Date:  2010-08-02       Impact factor: 6.998

5.  Disruption of Src function potentiates Chk1-inhibitor-induced apoptosis in human multiple myeloma cells in vitro and in vivo.

Authors:  Yun Dai; Shuang Chen; Rena Shah; Xin-Yan Pei; Li Wang; Jorge A Almenara; Lora B Kramer; Paul Dent; Steven Grant
Journal:  Blood       Date:  2010-12-10       Impact factor: 22.113

6.  Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation.

Authors:  Yun Dai; Payal Khanna; Shuang Chen; Xin-Yan Pei; Paul Dent; Steven Grant
Journal:  Blood       Date:  2007-01-30       Impact factor: 22.113

Review 7.  CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle.

Authors:  Paul Dent; Yong Tang; Adly Yacoub; Yun Dai; Paul B Fisher; Steven Grant
Journal:  Mol Interv       Date:  2011-04

8.  FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness.

Authors:  I-Ching Wang; Yi-Ju Chen; Douglas E Hughes; Timothy Ackerson; Michael L Major; Vladimir V Kalinichenko; Robert H Costa; Pradip Raychaudhuri; Angela L Tyner; Lester F Lau
Journal:  J Biol Chem       Date:  2008-06-04       Impact factor: 5.157

9.  Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells.

Authors:  Yun Dai; Shuang Chen; Xin-Yan Pei; Jorge A Almenara; Lora B Kramer; Charis A Venditti; Paul Dent; Steven Grant
Journal:  Blood       Date:  2008-07-09       Impact factor: 22.113

10.  MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism.

Authors:  Xin-Yan Pei; Yun Dai; Sarah Tenorio; Jianghua Lu; Hisashi Harada; Paul Dent; Steven Grant
Journal:  Blood       Date:  2007-05-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.